Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 2, 2004, Pages 235-241

  Tulic, Meri K ^a   Fiset, Pierre Olivier ^a   Christodoulopoulos, Pota ^a   Vaillancourt, Patrice ^a   Desrosiers, Martin ^b   Lavigne, François ^b   Eiden, Joseph ^c   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Dynavax Technologies Corporation   (United States)

Author keywords

Amb a 1 immunostimulatory phosphorothioate oligonucleotide conjugate; Immunotherapy; Ragweed; Rhinitis

Indexed keywords

ALLERGEN; AMB A 1 IMMUNOSTIMULATORY PHOSPHOROTHIOATE OLIGONUCLEOTIDE CONJUGATE; AMB A I PROTEIN, AMBROSIA ARTEMISIIFOLIA; BASIC PROTEIN; CYTOKINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; NUCLEOTIDE; OLIGONUCLEOTIDE; PLACEBO; RAGWEED ANTIGEN; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

ACTIVE IMMUNIZATION; ADULT; ALLERGIC RHINITIS; ARTICLE; BIOPSY; CELLULAR IMMUNITY; CHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DESENSITIZATION; DIZZINESS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HAY FEVER; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOLOGY; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; INFLAMMATION; LYMPHOCYTE COUNT; MALE; METABOLISM; NASAL BIOPSY; NAUSEA; NOSE MUCOSA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAGWEED; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SINGLE BLIND PROCEDURE; SYMPTOM; SYNCOPE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 1142273128     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.11.001     Document Type: Article

References (15)

1. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AM, Schwartz LB, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992;146:170-6.
2. Durham SR, Kay AB, Hamid Q. Changes in allergic inflammation associated with successful immunotherapy. Intern Arch Allergy Immunol 1995;107:282-4.
3. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996;97:1356-65.
4. Durham SR, Hamid QA. The effect of immunotherapy on allergen induced late responses. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1997;91:33-9.
5. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-75.
6. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in 1L-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-60.
7. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JD, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124-34.
8. Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F, et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes Th1 cytokine expression while downregulating Th2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001;108:191-7.
9. Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M. Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002;109:455-62.
10. Creticos PS, Eiden JJ, Balcer SL, Van Nest G, Kagey-Sobotka A, Tuck S, et al. Immunostimulatory oligonucleotides conjugated to Amb a 1: safety, skin test reactivity, and basophil histamine release. J Allergy Clin Immunol 2000;105(suppl):S70.
11. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, Zhang DH, et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 1999;103:215-22.
12. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-64.
13. Hamid Q, Wharton J, Terenghi G, Hassall CJ, Aimi J, Taylor KM, et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci USA 1987;84:6760-4.
14. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
15. Christodoulopoulos P, Lavigne F, Marshall J, Van Nest G, Eiden J, Hamid QA. Induction of a specific ThI response by allergen-linked immunostimulatory DNA in the nasal explant [abstract]. J Allergy Clinical Immunol 2002;109:A973:404-14.